Last reviewed · How we verify
Basdene (benzylthiouracil)
Basdene (generic name: benzylthiouracil) is a benzylthiouracil drug. It is currently in unknown development.
Basdene is thought to work by interacting with a specific molecular target, although its exact mechanism of action is currently unknown.
Basdene is a small molecule with an unknown mechanism of action. It is an antithyroid preparation, classified as a thioamide closely related to propylthiouracil.
At a glance
| Generic name | benzylthiouracil |
|---|---|
| Drug class | benzylthiouracil |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells have locks on them, and the key to unlocking these locks is a specific molecule. Basdene is like a key that fits into one of these locks, but we don't yet know which lock it is or how it works once inside. This interaction may help to treat certain conditions, but more research is needed to understand the details.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Basdene CI brief — competitive landscape report
- Basdene updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Basdene
What is Basdene?
How does Basdene work?
What is the generic name of Basdene?
What drug class is Basdene in?
What development phase is Basdene in?
Related
- Drug class: All benzylthiouracil drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing